Helicobacter pylori infection and lung cancer: A review of an emerging hypothesis

Carcinogenesis

Volumn 34, Issue 6, 2013, Pages 1189-1195

  Deng, Bo ^a,b   Li, Yafei ^c   Zhang, Yao ^c   Bai, Li ^c   Yang, Ping ^a  

^a MAYO CLINIC   (United States)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGENESIS ASSOCIATED PROTEIN; CYTOTOXIN; GASTRIN; PEPTIDES AND PROTEINS; PROTEIN P130; UNCLASSIFIED DRUG; UREASE;

CANCER RISK; CARCINOGENESIS; DISEASE ASSOCIATION; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTION; HUMAN; LUNG CANCER; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; UPPER RESPIRATORY TRACT;

ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CRK-ASSOCIATED SUBSTRATE PROTEIN; GASTRIC MUCOSA; GASTRINS; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LUNG NEOPLASMS; ODDS RATIO; STOMACH; UREASE;

EID: 84878964751     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt114     Document Type: Review

References (106)

1. Jiang,W. et al. (2012) Comparisons of multiple characteristics between young and old lung cancer patients. Chin. Med. J. (Engl)., 125, 72-80.
2. Samet,J.M. et al. (2009) Lung cancer in never smokers: clinical epidemiology and environmental risk factors. Clin. Cancer Res., 15, 5626-5645.
3. Yang,P. (2011) Lung cancer in never smokers. Semin. Respir. Crit. Care Med., 32, 10-21.
4. Zhao,P. et al. (2010) Cancer trends in China. Jpn. J. Clin. Oncol., 40, 281-285.
5. Thun,M.J. et al. (2008) Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies. PLoS Med., 5, e185.
6. Park,S.K. et al.; Scientific Committee, Korean Academy of Tuberculosis and Respiratory Diseases. (2010) Lung cancer risk and cigarette smoking, lung tuberculosis according to histologic type and gender in a population based case-control study. Lung Cancer, 68, 20-26.
7. Cardesa,A. et al. (2011) Carcinoma of the head and neck in the HPV era. Acta Dermatovenerol. Alp. Panonica. Adriat., 20, 161-173.
8. Nguyen,N.P. et al. (2010) Human papillomavirus-associated oropharyngeal cancer: a new clinical entity. QJM, 103, 229-236.
9. Priebe,A.M. (2013) 2012 cervical cancer screening guidelines and the future role of HPV testing. Clin. Obstet. Gynecol., 56, 44-50.
10. Raab-Traub,N. (2012) Novel mechanisms of EBV-induced oncogenesis. Curr. Opin. Virol., 2, 453-458.
11. Chen,J.N. et al. (2012) Epstein-Barr virus-associated gastric carcinoma: a newly defined entity. J. Clin. Gastroenterol., 46, 262-271.
12. Hippocrate,A. et al. (2011) Possible role of EBV in breast cancer and other unusually EBV-associated cancers. Cancer Lett., 305, 144-149.
13. de Martel,C. et al. (2012) Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol., 13, 607-615.
14. Banic,M. et al. (2012) Extragastric manifestations of Helicobacter pylori infection. Helicobacter, 17 (suppl. 1), 49-55.
15. Chey,W.D. et al.; Practice Parameters Committee of the American College of Gastroenterology. (2007) American College of Gastroenterology guideline on the management of Helicobacter pylori infection. Am. J. Gastroenterol., 102, 1808-1825.
16. Brown,L.M. (2000) Helicobacter pylori: epidemiology and routes of transmission. Epidemiol. Rev., 22, 283-297.
17. Behroozian,R. et al. (2010) The assessment of probable relationship between lung cancer and Helicobacter pylori infection. Trop. Gastroenterol., 31, 34-36.
18. Zhuo,W.L. et al. (2009) Assessment of the relationship between Helicobacter pylori and lung cancer: a meta-analysis. Arch. Med. Res., 40, 406-410.
19. No Authors. (1983) Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet, 1, 1273-1275.
20. Mitchell, H.M.(1999) The epidemiology of Helicobacter pylori. Curr. Top. Microbiol. Immunol., 241, 11-30.
21. Chow,W.H. et al. (1998) An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res., 58, 588-590.
22. Hansen,S. et al. (1999) Helicobacter pylori infection and risk of cardia cancer and non-cardia gastric cancer. A nested case-control study. Scand. J. Gastroenterol., 34, 353-360.
23. Oberg,S. et al. (1999) Helicobacter pylori is not associated with the manifestations of gastroesophageal reflux disease. Arch. Surg., 134, 722-726.
24. Lochhead,P. et al. (2007) Helicobacter pylori infection and gastric cancer. Best Pract. Res. Clin. Gastroenterol., 21, 281-297.
25. Suerbaum,S. et al. (2002) Helicobacter pylori infection. N. Engl. J. Med., 347, 1175-1186.
26. IARC (1994) Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. IARC Monographs on the Evaluation of Carcinogenic Risks to Human, Vol. 61. International Agency for Research on Cancer, Lyon, pp. 1-241.
27. Kusters,J.G. et al. (2006) Pathogenesis of Helicobacter pylori infection. Clin. Microbiol. Rev., 19, 449-490.
28. Schneider,S. et al. (2008) Targeting focal adhesions: Helicobacter pylorihost communication in cell migration. Cell Commun. Signal., 6, 2.
29. Wroblewski,L.E. et al. (2010) Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin. Microbiol. Rev., 23, 713-739.
30. Xiang,Z. et al. (1995) Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect. Immun., 63, 94-98.
31. Tegtmeyer,N. et al. (2011) Role of the cag-pathogenicity island encoded type IV secretion system in Helicobacter pylori pathogenesis. FEBS J., 278, 1190-1202.
32. Blaser,M.J. et al. (1995) Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res., 55, 2111-2115.
33. Hatakeyama,M. (2009) Helicobacter pylori and gastric carcinogenesis. J. Gastroenterol., 44, 239-248.
34. Parsonnet,J. et al. (1997) Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut, 40, 297-301.
35. Ohnishi,N. et al. (2008) Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc. Natl. Acad. Sci. U. S. A., 105, 1003-1008.
36. Atherton,J.C. (2006) The pathogenesis of Helicobacter pylori-induced gastro-duodenal diseases. Annu. Rev. Pathol., 1, 63-96.
37. Maeda,S. et al. (1998) Major virulence factors, VacA and CagA, are commonly positive in Helicobacter pylori isolates in Japan. Gut, 42, 338-343.
38. Jones,K.R. et al. (2011) Polymorphisms in the intermediate region of VacA impact Helicobacter pylori-induced disease development. J. Clin. Microbiol., 49, 101-110.
39. Atherton,J.C. et al. (1995) Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J. Biol. Chem., 270, 17771-17777.
40. Sugimoto,M. et al. (2009) The association of vacA genotype and Helicobacter pylori-related disease in Latin American and African populations. Clin. Microbiol. Infect., 15, 835-842.
41. Sugimoto,M. et al. (2009) The association of vacA genotypes and Helicobacter pylori-related gastroduodenal diseases in the Middle East. Eur. J. Clin. Microbiol. Infect. Dis., 28, 1227-1236.
42. Nguyen,T.L. et al. (2010) Helicobacter pylori infection and gastroduodenal diseases in Vietnam: a cross-sectional, hospital-based study. BMC Gastroenterol., 10, 114.
43. Yamaoka,Y. et al. (2002) Helicobacter pylori in North and South America before Columbus. FEBS Lett., 517, 180-184.
44. Jafarzadeh,A. et al. (2010) Serum concentrations of Helicobacter pylori IgG and the virulence factor CagA in patients with ischaemic heart disease. East. Mediterr. Health J., 16, 1039-1044.
45. Park,M.J. et al. (2011) Association between Helicobacter pylori Seropositivity and the Coronary Artery Calcium Score in a Screening Population. Gut Liver, 5, 321-327.
46. Schöttker,B. et al. (2012) Helicobacter pylori infection, chronic atrophic gastritis and major cardiovascular events: a population-based cohort study. Atherosclerosis, 220, 569-574.
47. Kikuchi,T. et al. (2011) Eight-year follow-up of patients with immune thrombocytopenic purpura related to H. pylori infection. Platelets, 22, 61-64.
48. Xia,W. et al. (2012) Survey of anaemia and Helicobacter pylori infection in adolescent girls in Suihua, China and enhancement of iron intervention effects by H. pylori eradication. Br. J. Nutr., 108, 357-362.
49. Malik,R. et al. (2011) Effect of Helicobacter pylori eradication therapy in iron deficiency anaemia of pregnancy - a pilot study. Indian J. Med. Res., 134, 224-231.
50. Kim,J.M. et al. (2011) Investigation of the association between Helicobacter pylori infection and normal tension glaucoma. Invest. Ophthalmol. Vis. Sci., 52, 665-668.
51. Akashi,R. et al. (2011) Clinical study of the relationship between Helicobacter pylori and chronic urticaria and prurigo chronica multiformis: effectiveness of eradication therapy for Helicobacter pylori. J. Dermatol., 38, 761-766.
52. Ben,M.L. et al. (2011) Helicobacter pylori associated with chronic urticaria. J. Infect. Dev. Ctries, 5, 596-598.
53. Ki,M.R. et al. (2010) Helicobacter pylori accelerates hepatic fibrosis by sensitizing transforming growth factor-β1-induced inflammatory signaling. Lab. Invest., 90, 1507-1516.
54. Silva,L.D. et al. (2011) The presence of Helicobacter pylori in the liver depends on the Th1, Th17 and Treg cytokine profile of the patient. Mem. Inst. Oswaldo Cruz, 106, 748-754.
55. Le,R.E. et al. (2012) Helicobacter infection induces podosome assembly in primary hepatocytes in vitro. Eur. J. Cell Biol., 91, 161-170.
56. Ataseven,H. et al. (2010) Effect of sequential treatment as a first-line therapy for Helicobacter pylori eradication in patients with diabetes mellitus. South. Med. J., 103, 988-992.
57. Suzuki,H. et al. (2011) Extragastric manifestations of Helicobacter pylori infection. Helicobacter, 16 (suppl. 1), 65-69.
58. Schimke,K. et al. (2010) Helicobacter pylori cytotoxin-associated gene- A antibodies do not predict complications or death in type 2 diabetes: the Fremantle Diabetes Study. Atherosclerosis, 212, 321-326.
59. Dobbs,S.M. et al. (2010) Differential effect of Helicobacter pylori eradication on time-trends in brady/hypokinesia and rigidity in idiopathic parkinsonism. Helicobacter, 15, 279-294.
60. Shiota,S. et al. (2011) The relationship between Helicobacter pylori infection and Alzheimer's disease in Japan. J. Neurol., 258, 1460-1463.
61. Kountouras,J. et al. (2011) Association between Helicobacter pylori infection and Alzheimer's disease in Japan. J. Neurol., 258, 2086.
62. Jesnowski,R. et al. (2010) Helicobacter pylori in autoimmune pancreatitis and pancreatic carcinoma. Pancreatology, 10, 462-466.
63. Selgrad,M. et al. (2012) Helicobacter pylori: gastric cancer and extragastric intestinal malignancies. Helicobacter, 17 (suppl. 1), 30-35.
64. Rezaii,J. et al. (2008) Association between Helicobacter pylori infection and laryngo-hypopharyngeal carcinoma: a case-control study and review of the literature. Head Neck, 30, 1624-1627.
65. Seoane,A. et al. (2005) Helicobacter pylori and gastric cancer: relationship with histological subtype and tumor location. Gastroenterol. Hepatol., 28, 60-64.
66. Abdel-Monem,M.H. et al. (2011) Detection of Helicobacter pylori in adenotonsillar tissue of children with chronic adenotonsillitis using rapidurease test, PCR and blood serology: a prospective study. Int. J. Pediatr. Otorhinolaryngol., 75, 568-572.
67. Borkowski,G. et al. (1997) A possible role of Helicobacter pylori infection in the etiology of chronic laryngitis. Eur. Arch. Otorhinolaryngol., 254, 481-482.
68. Bulut,Y. et al. (2006) Association of cagA+ Helicobacter pylori with adenotonsillar hypertrophy. Tohoku J. Exp. Med., 209, 229-233.
69. Cirak,M.Y. et al. (2003) Detection of Helicobacter pylori and its CagA gene in tonsil and adenoid tissues by PCR. Arch. Otolaryngol. Head. Neck Surg., 129, 1225-1229.
70. Elsheikh,M.N. et al. (2005) Prevalence of Helicobacter pylori DNA in recurrent aphthous ulcerations in mucosa-associated lymphoid tissues of the pharynx. Arch. Otolaryngol. Head. Neck Surg., 131, 804-808.
71. Kaptan,Z.K. et al. (2009) Determination of Helicobacter pylori in patients with chronic nonspecific pharyngitis. Laryngoscope, 119, 1479-1483.
72. Lin,H.C. et al. (2010) Difference of Helicobacter pylori colonization in recurrent inflammatory and simple hyperplastic tonsil tissues. Arch. Otolaryngol. Head. Neck Surg., 136, 468-470.
73. Morinaka,S. et al. (2003) Detection of Helicobacter pylori in nasal and maxillary sinus specimens from patients with chronic sinusitis. Laryngoscope, 113, 1557-1563.
74. Ozdek,A. et al. (2003) A possible role of Helicobacter pylori in chronic rhinosinusitis: a preliminary report. Laryngoscope, 113, 679-682.
75. Wibawa,T. et al. (2011) Isolation of viable Helicobacter pylori in the tonsillar tissues of chronic tonsillitis patients. J. Infect. Dev. Ctries., 5, 561-564.
76. Angrill,J. et al. (2006) Does Helicobacter pylori have a pathogenic role in bronchiectasis? Respir. Med., 100, 1202-1207.
77. Gülhan,M. et al. (2007) Helicobacter pylori in bronchiectasis: a polymerase chain reaction assay in bronchoalveolar lavage fluid and bronchiectatic lung tissue. Arch. Med. Res., 38, 317-321.
78. Malfertheiner,M.V. et al. (2011) Helicobacter pylori infection and the respiratory system: a systematic review of the literature. Digestion, 84, 212-220.
79. Roussos,A. et al. (2006) Respiratory diseases and Helicobacter pylori infection: is there a link? Respiration., 73, 708-714.
80. Caselli,M. et al. (1999) Helicobacter pylori and chronic bronchitis. Scand. J. Gastroenterol., 34, 828-830.
81. Kanbay,M. et al. (2005) Helicobacter pylori seroprevalence in patients with chronic bronchitis. Respir. Med., 99, 1213-1216.
82. Jun,Z.J. et al. (2006) High seroprevalence of Helicobacter pylori in chronic bronchitis among Chinese population. Tohoku J. Exp. Med., 208, 327-331.
83. Roussos,A. et al. (2005) Helicobacter pylori seroprevalence in patients with chronic obstructive pulmonary disease. Respir. Med., 99, 279-284.
84. Filippou,N. et al. (2002) Helicobacter pylori seroprevalence in patients with pulmonary tuberculosis. J. Clin. Gastroenterol., 34, 189-190.
85. Fullerton,D. et al. (2009) Helicobacter pylori and lung function, asthma, atopy and allergic disease-a population-based cross-sectional study in adults. Int. J. Epidemiol., 38, 419-426.
86. Tsang,K.W. et al. (2000) Helicobacter pylori sero-prevalence in asthma. Respir. Med., 94, 756-759.
87. Jun,Z.J. et al. (2005) Helicobacter pylori seroprevalence in patients with mild asthma. Tohoku J. Exp. Med., 207, 287-291.
88. Mitz,H.S. et al. (1993) Demonstration of Helicobacter pylori in tracheal secretions. J. Am. Osteopath. Assoc., 93, 87-91.
89. Kanbay,M. et al. (2007) Helicobacter pylori infection as a possible risk factor for respiratory system disease: a review of the literature. Respir. Med., 101, 203-209.
90. Khamri,W. et al. (2010) Helicobacter pylori stimulates dendritic cells to induce interleukin-17 expression from CD4+ T lymphocytes. Infect. Immun., 78, 845-853.
91. Ece,F. et al. (2005) Does Helicobacter pylori infection play a role in lung cancer? Respir. Med., 99, 1258-1262.
92. Gocyk,W. et al. (2000) Helicobacter pylori, gastrin and cyclooxygenase-2 in lung cancer. Med. Sci. Monit., 6, 1085-1092.
93. Najafizadeh,K. et al. (2007) H. pylori seroprevalence in patients with lung cancer. World J. Gastroenterol., 13, 2349-2351.
94. Philippou,N. et al. (2004) Helicobacter pylori seroprevalence in patients with lung cancer. World J. Gastroenterol., 10, 3342-3344.
95. Koshiol,J. et al. (2012) Helicobacter pylori seropositivity and risk of lung cancer. PLoS One, 7, e32106.
96. Backert,S. et al. (2008) Emerging roles of Abl family tyrosine kinases in microbial pathogenesis. Trends Biochem. Sci., 33, 80-90.
97. Higashi,H. et al. (2002) Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc. Natl. Acad. Sci. U. S. A., 99, 14428-14433.
98. Hatakeyama,M. (2003) Helicobacter pylori CagA-a potential bacterial oncoprotein that functionally mimics the mammalian Gab family of adaptor proteins. Microbes Infect., 5, 143-150.
99. Slomiany,B.L. et al. (2011) Role of ghrelin-induced cSrc activation in modulation of gastric mucosal inflammatory responses to Helicobacter pylori. Inflammopharmacology, 19, 197-204.
100. Zhao,D. et al. (2010) Helicobacter pylori CagA upregulation of CIP2A is dependent on the Src and MEK/ERK pathways. J. Med. Microbiol., 59, 259-265.
101. Gu,J. et al. (2001) Laminin-10/11 and fibronectin differentially regulate integrin-dependent Rho and Rac activation via p130(Cas)-CrkIIDOCK180 pathway. J. Biol. Chem., 276, 27090-27097.
102. Huang,W. et al. (2012) BCAR1 protein plays important roles in carcinogenesis and predicts poor prognosis in non-small-cell lung cancer. PLoS One, 7, e36124.
103. Wei,L. et al. (2002) Anchorage-independent phosphorylation of p130(Cas) protects lung adenocarcinoma cells from anoikis. J. Cell. Biochem., 87, 439-449.
104. Wu,C.H. et al. (2007) Overexpression of Helicobacter pylori-associated urease mRNAs in human gastric cancer. DNA Cell Biol., 26, 641-648.
105. Herndon,B. et al. (2013) Urease and Helicobacter spp. antigens in pulmonary granuloma. J. Comp. Pathol., 148, 266-277.
106. Subramaniam,D. et al. (2008) Gastrin-mediated interleukin-8 and cyclooxygenase-2 gene expression: differential transcriptional and posttranscriptional mechanisms. Gastroenterology, 134, 1070-1082.